Servizo de Toxicoloxía, Instituto de Ciencias Forenses, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Department of Sciences, John Jay College of Criminal Justice, City University of New York, 10019 New York, NY, USA.
J Anal Toxicol. 2020 Jul 31;44(6):580-588. doi: 10.1093/jat/bkaa012.
An LC-MS-MS method for the determination of 14 benzodiazepines (BZDs) (alprazolam, α-hydroxyalprazolam, clonazepam, bromazepam, diazepam, nordiazepam, lorazepam, lormetazepam, oxazepam, flunitrazepam, 7-aminoflunitrazepam, triazolam, midazolam and zolpidem) and 15 antidepressants (ADs) (amitriptyline, nortriptyline, imipramine, desipramine, clomipramine, norclomipramine, fluoxetine, norfluoxetine, sertraline, norsertraline, paroxetine, venlafaxine, desmethylvenlafaxine, citalopram and desmethylcitalopram) in meconium was developed and validated. Meconium samples (0.25 ± 0.02 g) were homogenized in methanol and subjected to mixed-mode cation exchange solid-phase extraction. Chromatographic separation was performed in reversed phase, with a gradient of 0.1% formic acid in 2 mM ammonium formate and acetonitrile. Two different chromatographic gradient methods were employed, one for the separation of ADs and another for BZDs. Analytes were monitored by tandem mass spectrometry employing electrospray positive mode in MRM mode (2 transitions per compound). Method validation included: linearity [n = 5, limit of quantification (LOQ) to 400 ng/g], limits of detection (n = 6, 1-20 ng/g), LOQ (n = 9, 5-20 ng/g), selectivity (no endogenous or exogenous interferences), accuracy (n = 15, 90.6-111.5%), imprecision (n = 15, 0-14.6%), matrix effect (n = 10, -73 to 194.9%), extraction efficiency (n = 6, 35.9-91.2%), process efficiency (n = 6, 20.1-188.2%), stability 72 h in the autosampler (n = 3, -8.5 to 9%) and freeze/thaw stability (n = 3, -1.2 to -47%). The method was applied to four meconium specimens, which were analyzed with and without hydrolysis (enzymatic and alkaline). The authentic meconium samples tested positive for alprazolam, α-hydroxyalprazolam, clonazepam, diazepam, nordiazepam, fluoxetine, norfluoxetine, clomipramine and norclomipramine. Therefore, the present LC-MS-MS method allows a high throughput determination of the most common BZDs and ADs in meconium, which could be useful in clinical and forensic settings.
建立并验证了一种测定粪便中 14 种苯二氮䓬类药物(BZDs)(阿普唑仑、α-羟基阿普唑仑、氯硝西泮、溴替唑仑、地西泮、去甲西泮、劳拉西泮、氯美扎酮、奥沙西泮、氟硝西泮、7-氨基氟硝西泮、三唑仑、咪达唑仑和唑吡坦)和 15 种抗抑郁药(ADs)(阿米替林、去甲替林、丙咪嗪、去甲丙咪嗪、氯米帕明、去甲氯米帕明、氟西汀、去甲氟西汀、舍曲林、去甲舍曲林、帕罗西汀、文拉法辛、去甲基文拉法辛、西酞普兰和去甲基西酞普兰)的 LC-MS-MS 方法。将 0.25±0.02 g 粪便样本匀浆于甲醇中,并用混合模式阳离子交换固相萃取进行处理。采用反相色谱,以 0.1%甲酸在 2 mM 甲酸铵和乙腈中的梯度洗脱进行色谱分离。采用两种不同的色谱梯度方法,一种用于分离 ADs,另一种用于分离 BZDs。采用电喷雾正模式在 MRM 模式下(每种化合物 2 个转换)进行串联质谱检测。方法验证包括:线性(n=5,定量下限为 400 ng/g)、检测限(n=6,1-20 ng/g)、定量下限(n=9,5-20 ng/g)、选择性(无内源性或外源性干扰)、准确度(n=15,90.6-111.5%)、精密度(n=15,0-14.6%)、基质效应(n=10,-73 至 194.9%)、提取效率(n=6,35.9-91.2%)、过程效率(n=6,20.1-188.2%)、自动进样器中 72 h 的稳定性(n=3,-8.5 至 9%)和冻融稳定性(n=3,-1.2 至-47%)。该方法应用于 4 个粪便标本,分别进行了未水解(酶解和碱性水解)和水解后的分析。经鉴定,真实的粪便样本中阿普唑仑、α-羟基阿普唑仑、氯硝西泮、地西泮、去甲西泮、氟西汀、去甲氟西汀、氯米帕明和去甲氯米帕明呈阳性。因此,本 LC-MS-MS 方法可用于高通量测定粪便中最常见的 BZDs 和 ADs,这在临床和法医领域可能很有用。